| Literature DB >> 26084794 |
Yan Xu1, Ya-Xin Ding1, Jun Ding1, Ya-Hui Lei1, Ling-Yun Wu2, Nai-Yang Deng3.
Abstract
Lysine succinylation in protein is one type of post-translational modifications (PTMs). Succinylation is associated with some diseases and succinylated sites data just has been found in recent years in experiments. It is highly desired to develop computational methods to identify the candidate proteins and their sites. In view of this, a new predictor called iSuc-PseAAC was proposed by incorporating the peptide position-specific propensity into the general form of pseudo amino acid composition. The accuracy is 79.94%, sensitivity 51.07%, specificity 89.42% and MCC 0.431 in leave-one-out cross validation with support vector machine algorithm. It demonstrated by rigorous leave-one-out on stringent benchmark dataset that the new predictor is quite promising and may become a useful high throughput tool in this area. Meanwhile a user-friendly web-server for iSuc-PseAAC is accessible at http://app.aporc.org/iSuc-PseAAC/. Users can easily obtain their desired results without the need to understand the complicated mathematical equations presented in this paper just for its integrity.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26084794 PMCID: PMC4471726 DOI: 10.1038/srep10184
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
The number of positive and negative peptides in the benchmark dataset .
| No. | Positive | Negative |
|---|---|---|
| Homologous | 2521 | 24128 |
| Non-redundancy | 1167 | 3553 |
Figure 1A flowchart of the iSuc-PseAAC predictor.
The 10-fold, 8-fold and 6-fold cross-validation results by the predictor on the benchmark dataset .
| 10-fold | 50.65 ± 0.63 | 89.67 ± 0.27 | 80.02 ± 0.27 | 0.782 ± 0.003 | 0.432 ± 0.007 |
| 8-fold | 50.25 ± 0.90 | 89.65 ± 0.34 | 79.91 ± 0.27 | 0.782 ± 0.002 | 0.428 ± 0.007 |
| 6-fold | 49.95 ± 0.62 | 89.70 ± 0.35 | 79.87 ± 0.35 | 0.781 ± 0.002 | 0.426 ± 0.009 |
| LOO | 51.07 | 89.42 | 79.94 | 0.782 | 0.431 |
The experiments have been executed 30 times for every cross-validation and the results were the mean standard variation.
Figure 2The ROC curves for the LOO test and 6-, 8-, 10-fold cross-validations.
Figure 3The predicted results of the predictor iSuc-PseAAC.